The HFE p.H63D (p.His63Asp) Polymorphism Is a Modifier of ALS Outcome in Italian and French Patients with SOD1 Mutations.

Canosa A, Calvo A, Mora G, Moglia C, Brunetti M, Barberis M, Borghero G, Caponnetto C, Trojsi F, Spataro R, Volanti P, Simone IL, Salvi F, Logullo FO, Riva N, Tremolizzo L, Giannini F, Mandrioli J, Tanel R, Murru MR, Mandich P, Conforti FL, Zollino M, Sabatelli M, Tarlarini C, Lunetta C, Mazzini L, D'Alfonso S, Guy N, Meininger V, Clavelou P, Camu W, Chiò A, On Behalf Of Italsgen Consortium

Open source

DOI
10.3390/biomedicines11030704
Published
2023 Feb 24
Container
Biomedicines
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines11030704,
  title = {The HFE p.H63D (p.His63Asp) Polymorphism Is a Modifier of ALS Outcome in Italian and French Patients with SOD1 Mutations.},
  author = {Canosa A and Calvo A and Mora G and Moglia C and Brunetti M and Barberis M and Borghero G and Caponnetto C and Trojsi F and Spataro R and Volanti P and Simone IL and Salvi F and Logullo FO and Riva N and Tremolizzo L and Giannini F and Mandrioli J and Tanel R and Murru MR and Mandich P and Conforti FL and Zollino M and Sabatelli M and Tarlarini C and Lunetta C and Mazzini L and D'Alfonso S and Guy N and Meininger V and Clavelou P and Camu W and Chiò A and On Behalf Of Italsgen Consortium},
  year = {2023},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines11030704},
  url = {https://doi.org/10.3390/biomedicines11030704}
}

RIS

TY  - JOUR
TI  - The HFE p.H63D (p.His63Asp) Polymorphism Is a Modifier of ALS Outcome in Italian and French Patients with SOD1 Mutations.
AU  - Canosa A
AU  - Calvo A
AU  - Mora G
AU  - Moglia C
AU  - Brunetti M
AU  - Barberis M
AU  - Borghero G
AU  - Caponnetto C
AU  - Trojsi F
AU  - Spataro R
AU  - Volanti P
AU  - Simone IL
AU  - Salvi F
AU  - Logullo FO
AU  - Riva N
AU  - Tremolizzo L
AU  - Giannini F
AU  - Mandrioli J
AU  - Tanel R
AU  - Murru MR
AU  - Mandich P
AU  - Conforti FL
AU  - Zollino M
AU  - Sabatelli M
AU  - Tarlarini C
AU  - Lunetta C
AU  - Mazzini L
AU  - D'Alfonso S
AU  - Guy N
AU  - Meininger V
AU  - Clavelou P
AU  - Camu W
AU  - Chiò A
AU  - On Behalf Of Italsgen Consortium
PY  - 2023
JO  - Biomedicines
DO  - 10.3390/biomedicines11030704
UR  - https://doi.org/10.3390/biomedicines11030704
ER  -

APA

A, C., A, C., G, M., C, M., M, B., M, B., G, B., C, C., F, T., R, S., P, V., IL, S., F, S., FO, L., N, R., L, T., F, G., J, M., R, T., MR, M., P, M., FL, C., M, Z., M, S., C, T., C, L., L, M., S, D., N, G., V, M., P, C., W, C., A, C., & Consortium, O. B. O. I. (2023). The HFE p.H63D (p.His63Asp) Polymorphism Is a Modifier of ALS Outcome in Italian and French Patients with SOD1 Mutations.. Biomedicines. https://doi.org/10.3390/biomedicines11030704

Source records